Navigation Links
How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options
Date:9/4/2007

BOSTON, Sept. 4 /PRNewswire-USNewswire/ -- Attention-deficit/hyperactivity disorder (ADHD) is no longer diagnosed just in schoolchildren. ADHD has already become the most common mental health diagnosis for children ages 3 to 5. Researchers have now begun to explore the use of drugs and other treatments for preschoolers, reports the September 2007 issue of the Harvard Mental Health Letter.

At the preschool age, it can be hard to tell whether certain behaviors represent a real problem or just "kids being kids." Clinicians compare a child with others the same age to determine whether the symptoms are inconsistent with the developmental level. Preschoolers with ADHD are not just rambunctious. They seem unable to wait their turn or think before acting. Despite warnings, they may play with matches or rush into traffic. They are noisy and constantly interrupt others, and they can sow chaos at home or in day care.

Stimulant drugs are increasingly prescribed for younger children, although the FDA has not approved them for children under age 6. The first large, controlled trial of methylphenidate (Ritalin and others) in children ages 3 to 5 found the drug was not quite as effective as it is in school-age children.

The most popular alternative to drug treatment is parent training, which is based on the belief that parental negligence, intrusiveness, or harsh discipline might trigger hyperactive behavior in a child with a predisposition to poor impulse control. Parents are shown how to set appropriate limits and use moderate rewards and punishments. The bottom line, according to the Harvard Mental Health Letter: Be slow to make the diagnosis, and consider parent training and specialized day care before resorting to stimulant drugs.

Also in this issue:

-- Endophenotypes: A new way to look at psychiatric disorders

-- Ignoring hallucinatory voices

-- When both partners are violent

-- Muscle relaxation

-- Borderline personality disorder

-- Children, depression, and the FDA

The Harvard Mental Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $59 per year. Subscribe at http://www.health.harvard.edu/mental or by calling 1-877-649-9457 (toll free).

Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.


'/>"/>
SOURCE Harvard Mental Health Letter
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Thyroid hormone treatment hastens recovery after cardiac surgery
4. Feeding channel created by malaria parasite - a new target for malaria treatments
5. New drug to treat Heart Attack and damaged tissue
6. Now umbilical cord helps in stroke treatment.
7. Now AIDS treatment comes dirt-cheap
8. Breast cancer treatment to be determined by gene test
9. Hemopurifier may revolutionise AIDS treatment
10. New drug helps boost cancer treatment
11. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Doylestown, Pa. (PRWEB) , ... ... ... leading provider of technology-enabled clinical trial solutions, today announced the further expansion ... types of applications they can leverage as part of Bioclinica’s extensive and ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article ... weight loss. It found that the treatments have led to significant improvements in weight ... to unassisted efforts. It also noted very few problematic results relating to the treatment. ...
(Date:2/20/2017)... ... February 21, 2017 , ... Nancy Johnston Toll marks her debut ... Getting Over the Bump in the Road ” (published by Xlibris). Inspired from her ... cope with the ups and downs experienced by anyone going through cancer treatment and ...
(Date:2/20/2017)... ... February 20, 2017 , ... Researchers at the University of ... well as a marker that may predict response to a particular class of drugs, ... of cancer as well. The new findings were published in Proceedings of the National ...
(Date:2/20/2017)... ... 2017 , ... Best Doctors® and IBM today announced that ... that want to help members of their workforce battling cancer. Through the Best ... suite of oncology offerings for insights on cancer treatment options, ranging from standard ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Lexmark International, ... solution that connects Lexmark multifunction printers (MFPs) to EDCO ... leading scanning and indexing software solutions for medical records. ... use a Lexmark MFP at the point of care ... facilities reach HIMSS Stage 7 through state-of-the-art ...
(Date:2/21/2017)... IDAHO FALLS, Idaho , Feb. 21, 2017 /PRNewswire/ ... is has completed a private placement with certain investors ... preferred stock of the Company, Series C Convertible Redeemable ... Stock accrues dividends at an annual rate of 6% ... share.  The Company plans to use the proceeds for ...
(Date:2/21/2017)... SAN JOSE, Calif. , Feb. 21, 2017 ... announced that its Cadence ® Tensilica ® Fusion ... HaLow ™ MAC IP offering. The licensable IP targets ... smart city and industrial applications. M2B leveraged the Fusion F1 ... to run value-added applications like voice trigger, audio identification and ...
Breaking Medicine Technology: